Stylus Medicine (Series A extension)
Funding Details
- Awarder
- Inbox
- Date Award
- May 13, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $85,000,000
Company Info
- Company Description
- Stylus Medicine is a biotechnology company dedicated to developing transformative in vivo genetic medicines to unlock cures. Stylus combines engineered recombinases with non-viral delivery to specifically encode therapeutics.
- Market
- Genetic Medicines
- Location
- Cambridge, MA, USA
- Coinvestors
- RA Capital Management, Khosla Ventures, Chugai Venture Fund, Eli Lilly and Company, Johnson & Johnson Innovation - JJDC